v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

The following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act) or director who entered into, modified or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the three months ended June 30, 2024:

Name and Title

 

Type of Trading Arrangement

 

Action Taken
(Date of Action)

 

Duration or End Date

 

Aggregate Number of Securities to be Sold

 

 

Description
of Trading
Arrangement

William Savage, M.D., Ph.D.
Chief Medical Officer

 

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

 

Adoption
(
April 12, 2024)

 

End Date
(
September 30, 2024)

 

 

3,000

 

 

Sale

Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Rule 10b5-1 Arrangement Modified false
Non-Rule 10b5-1 Arrangement Modified false
William Savage [Member]  
Trading Arrangements, by Individual  
Name William Savage
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 12, 2024
Expiration Date September 30, 2024
Arrangement Duration 171 days
Aggregate Available 3,000